{"product_id":"molecular-techniques-for-the-study-of-hospital-acquired-infection-isbn-9780470420850","title":"Molecular Techniques for the Study of Hospital Acquired Infection","description":"Providing a broad overview of the microbial pathogens associated with hospital-acquired human illness, \u003ci\u003eTechniques for the Study of Hospital Acquired Infection\u003c\/i\u003e examines the cost-effective use of laboratory techniques in nosocomial infectious disease epidemiology and control. This concise guide addresses the cost benefits of combining modern molecular techniques with the traditional activities of infection control departments. The book is useful as a guide to hospital infection control programs as well as a text for medical practitioners, grad\/medical students, researcher scientists, population biologists, molecular biologists, and microbiologists.  Contributors.  \u003cp\u003eForword.\u003c\/p\u003e \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003eDedication.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eI. Introduction to Healthcare Associated Infections and Their Control.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. The Hospital and Ambulatory Care Environment (\u003ci\u003eAnne Y. Chen and Hiren Pokharma\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e2. Pathogen Transmission in the Healthcare Setting (\u003ci\u003eSonja Hansen and Ralf-Peter Vonberg\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e3. Infection Control Basics (\u003ci\u003eLouise-Marie Dembry and Carlos Torres-Viera\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e4. Cost-Effectiveness of IC Program (\u003ci\u003eMarc-Oliver Wright and Eli N. Perencevich\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e5. Outbreak Investigations (Importance of the Healthcare Epidemiologist) (\u003ci\u003eMarcus J. Zervos\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e6. Pathogen Elimination: Antibiotic and Disinfectant Use and the Development of Resistance (\u003ci\u003eSteven L. Foley, Beilei Ge, Carl M. Schroeder, and Arron M. Lynne\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eII. Techniques to Characterize Nosocomial Pathogens.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7. Rapid PCR Screening Methods (\u003ci\u003eNgolela Esther Babady, Frankling Cockerill and Robin Patel\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e8. Restriction Analysis Techniques (\u003ci\u003eRichard V. Goering, Mary Stemper, SanjayShukla and Steven Foley\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e9. Pulsed-field Gel Electrophoresis (\u003ci\u003eMary Stemper, Steven Foley Richard V. Goering, and Sanjay Shukla\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIII. Application of Techniques to Characterize Predominant Nosocomial Pathogens.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10. Staphylococcus aureus (\u003ci\u003eVanthida Huang\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e11. Escherichia coli (\u003ci\u003eJohann D. D. Pitout\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e12. Fungal Infections (\u003ci\u003eJose A. Vazquez\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eIndex. \u003c\/p\u003e \u003cp\u003e\u003cb\u003eShabbir Simjee\u003c\/b\u003e, Ph.D. is a Senior Microbiologist at Eli Lilly \u0026amp; Company, where he specializes in antimicrobial susceptibility testing and the interpretation of antimicrobial susceptibility data according to NCCLS and BSAC standards. He has served as Editor of \u003ci\u003eThe Journal of Antimicrobial Chemotherapy\u003c\/i\u003e and currently serves as an Editorial Board Member for \u003ci\u003eAntimicrobial Agents and Chemotherapy\u003c\/i\u003e as well as Section Editor (Molecular Microbiology) for the \u003ci\u003eInternational Journal of Antimicrobial Agents\u003c\/i\u003e. Dr. Simjee has served on a number of FDA advisory committees.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSteven Foley\u003c\/b\u003e, Ph.D. is an Associate Research Scientist for the National Farm Medicine Center, Marshfield Clinic Research Foundation, as well as Clinical Professor of Clinical Microbiology at the University of Wisconsin. His research interests include understanding the mechanisms that Escherichia coli employ to resist being killed by vertebrate immune system constituents and the development and utilization of genotypic and phenotypic methods to track enteric bacterial pathogens and their virulence and antimicrobial resistance factors through the food animal production environment.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAnne Chen\u003c\/b\u003e, M.D. is a Senior Staff Physician, Division of Infectious Diseases at the Henry Ford Hospital, Detroit, Michigan as well as Assistant Professor of Medicine at Wayne State University School of Medicine. She is Board Certified in Internal Medicine and Infectious Disease and is currently researching Candida epidemiology in the burn unit.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eMarcus J. Zervos\u003c\/b\u003e, M.D. is the Medical Director of Infection Control and Division Head of Infectious Disease, Department of Internal Medicine at Henry Ford Hospital as well as Clinical Professor of Medicine in the Department of Internal Medicine, Infectious Diseases Section at Wayne State University School of Medicine. He chairs the Infection Control Committee at the Henry Ford Hospital and is certified by the American Board of Internal Medicine and Infectious Diseases. Dr. Zervos serves on the boards of several journals in infectious disease, microbiology and internal medicine, including Infectious Diseases in Clinical Practice and his role as Section Editor for the journal \u003ci\u003eInfection Control and Hospital Epidemiology\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eLatest findings, practices, and strategies to detect and control nosocomial infections\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNosocomial infections, also known as hospital acquired infections, represent a growing challenge to healthcare facilities around the world. Many nosocomial pathogens are becoming more and more resistant to treatment, resulting in higher morbidity, mortality, and cost. In fact, each year it is estimated that some two million patients develop a hospital-acquired infection in the United States, representing nearly 5% of all hospitalized patients.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMolecular Techniques for the Study of Hospital Acquired Infection\u003c\/i\u003e reviews the latest findings, practices, and strategies to support the development and implementation of effective, comprehensive programs to study and control hospital acquired infections. It focuses on the application of molecular techniques, enabling hospitals to incorporate these state-of-the-technology techniques into their infection control programs.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eKey topics include:\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eCharacteristics of healthcare settings that allow for the development and spread of nosocomial pathogens\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eImplementation of effective infection control programs\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eEpidemiological methods to study nosocomial disease\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eElimination of pathogens and the development of resistance to treatment\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eMolecular techniques to study hospital acquired infections and their application in characterizing important Gram-positive, Gram-negative, and fungal pathogens\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eContributions come from leading international experts in nosocomial pathogen detection and control. These contributions are based on the authors' own firsthand experience combined with a thorough review and analysis of the current literature. References at the end of each chapter enable readers to explore each individual topic in greater depth.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMolecular Techniques for the Study of Hospital Acquired Infection\u003c\/i\u003e is highly recommended as a guide for hospital infection control programs. Moreover, it serves as a text for courses in infection control and the population biology of nosocomial infection. In particular, the book's unique clinical perspective helps readers minimize nosocomial infections by developing a coordinated approach to infection control, laboratory methods, and clinical practices.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989649834213,"sku":"NP9780470420850","price":184.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470420850.jpg?v=1761784958","url":"https:\/\/k12savings.com\/products\/molecular-techniques-for-the-study-of-hospital-acquired-infection-isbn-9780470420850","provider":"K12savings","version":"1.0","type":"link"}